Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease?

被引:15
作者
Anagnostis, P. [1 ]
Boboridis, K. [2 ]
Adamidou, F. [1 ]
Kita, M. [1 ]
机构
[1] Hippokrat Hosp Thessaloniki, Dept Endocrinol & Diabet, Sarantaporou 10, Thessaloniki 54640, Greece
[2] Aristotle Univ Thessaloniki, Univ Dept Ophthalmol 1, Thessaloniki, Greece
来源
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 2017年 / 40卷 / 03期
关键词
Graves' disease; Graves' orbitopathy; Natural course; TERM-FOLLOW-UP; OPHTHALMOPATHY; HISTORY; HYPERTHYROIDISM; EXOPHTHALMOS; PREVALENCE; MANAGEMENT;
D O I
10.1007/s40618-016-0555-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/ Aims The natural course of Graves' orbitopathy ( GO) has been poorly documented. The aim of this review is to provide current knowledge regarding the natural course of mild GO, trying to address the issue of whether and to what extent it constitutes a chronic remitting or transient disease. Methods We systematically searched PubMed for English language publications until August 2016 under the following terms: " Graves' orbitopathy" OR " Graves' ophthalmopathy" OR " thyroid eye disease" AND " natural course" OR " natural history". Results Few studies have investigated the course of mild orbital disease in patients with GO. Large controlled trials are lacking and data can be extracted mainly from small retrospective and some prospective studies, after excluding patients who had received radioiodine for thyrotoxicosis or surgical treatment for GO. In general, more than half of GO patients may show spontaneous improvement in their clinical features, whereas no safe conclusions can be drawn with regard to complete resolution, with percentages ranging from 6 to 58 %. Conclusions The question whether mild GO is a remitting, albeit chronic disease, or even a transient event in the course of Graves' disease, remains currently unanswered.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 19 条
[1]  
AGAPITOS PJ, 1987, CAN MED ASSOC J, V136, P369
[2]  
Anagnostis Panagiotis, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-010305
[3]   Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement [J].
Bartalena, L. ;
Macchia, P. E. ;
Marcocci, C. ;
Salvi, M. ;
Vermiglio, F. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2015, 38 (04) :481-487
[4]   The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy [J].
Bartalena, Luigi ;
Baldeschi, Lelio ;
Boboridis, Kostas ;
Eckstein, Anja ;
Kahaly, George J. ;
Marcocci, Claudio ;
Perros, Petros ;
Salvi, Mario ;
Wiersinga, Wilmar M. .
EUROPEAN THYROID JOURNAL, 2016, 5 (01) :9-26
[5]   Extrathyroidal manifestations of Graves' disease: a 2014 update [J].
Bartalena, Luigi ;
Fatourechi, Vahab .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (08) :691-700
[6]   Long-term follow-up of Graves ophthalmopathy in an incidence cohort [J].
Bartley, GB ;
Fatourechi, V ;
Kadrmas, EF ;
Jacobsen, SJ ;
Ilstrup, DM ;
Garrity, JA ;
Gorman, CA .
OPHTHALMOLOGY, 1996, 103 (06) :958-962
[7]  
Marcocci C, 1999, CLIN ENDOCRINOL, V51, P503
[8]   Selenium and the Course of Mild Graves' Orbitopathy [J].
Marcocci, Claudio ;
Kahaly, George J. ;
Krassas, Gerasimos E. ;
Bartalena, Luigi ;
Prummel, Mark ;
Stahl, Matthias ;
Altea, Maria Antonietta ;
Nardi, Marco ;
Pitz, Susanne ;
Boboridis, Kostas ;
Sivelli, Paolo ;
von Arx, George ;
Mourits, Maarten P. ;
Baldeschi, Lelio ;
Bencivelli, Walter ;
Wiersinga, Wilmar .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20) :1920-1931
[9]   Spontaneous Improvement of Untreated Mild Graves' Ophthalmopathy: Rundle's Curve Revisited [J].
Menconi, Francesca ;
Profilo, Maria Antonietta ;
Leo, Marenza ;
Sisti, Eleonora ;
Altea, Maria Antonietta ;
Rocchi, Roberto ;
Latrofa, Francesco ;
Nardi, Marco ;
Vitti, Paolo ;
Marcocci, Claudio ;
Marino, Michele .
THYROID, 2014, 24 (01) :60-66
[10]  
Noth D, 2001, SWISS MED WKLY, V131, P603